New medication treats drug-resistant prostate cancer in the laboratory
A new drug called pyrvinium pamoate inhibits aggressive forms of prostate cancer that are resistant to standard drugs, according to a study conducted in an animal model. The results will be presented Monday at The Endocrine ...
Jun 17, 2013
0
0